日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

BCMA-targeted therapies for multiple myeloma: latest updates from 2024 ASH annual meeting

BCMA靶向疗法治疗多发性骨髓瘤：2024年ASH年会最新进展

期刊:Journal of Hematology & Oncology
影响因子:40.4
doi:10.1186/s13045-025-01675-5
Zheng, Huijian; Xian, Huajian; Zhang, Wenjie; Lu, Chaoqun; Pan, Renyao; Liu, Han; Xu, Zhenshu
多发性骨髓瘤
骨髓瘤
发表日期：2025
文献求助 收藏

Enhancing Anti-Tumor Effects of Engineered Extracellular Vesicles via Endocytosis Route Switching and Interferon Response Suppression.

通过胞吞途径转换和干扰素反应抑制增强工程化细胞外囊泡的抗肿瘤作用。

期刊:Advanced Science
影响因子:14.1
doi:10.1002/advs.202515472
Huang Zixuan, Lu Chaoqun, Wang Yixin, Xian Huajian, Zheng Yuling, Kang Ting, Xiang Rufang, Xie Shufeng, Wang Minghui, Li Zeyi, Xia Xiaoli, Yu Yaoyifu, Zhang Wenjie, Zheng Huijian, Pan Renyao, Li Dan, Zhao Chunjun, Liu Han
细胞生物学
囊泡
发表日期：2025
文献求助 收藏

Establishment of a prognostic model based on ER stress-related cell death genes and proposing a novel combination therapy in acute myeloid leukemia.

建立基于内质网应激相关细胞死亡基因的预后模型，并提出急性髓系白血病的新联合治疗方案

期刊:Journal of Translational Medicine
影响因子:7.5
doi:10.1186/s12967-025-06615-y
Wang Minghui, Xian Huajian, Xia Xiaoli, Zhang Wenjie, Huang Zixuan, Lu Chaoqun, Zheng Yuling, Wang Yixin, Xie Shufeng, Pan Renyao, Yu YaoYifu, Wang Ruiheng, Zheng Huijian, Huang Guorui, Liu Han
细胞生物学
白血病
氧化应激
发表日期：2025
文献求助 收藏

Analysis of early efficacy and immune reconstitution after autologous hematopoietic stem cell transplantation in multiple myeloma

多发性骨髓瘤自体造血干细胞移植后早期疗效和免疫重建的分析

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-024-84047-2
Chen, Kaili; Liang, Huixin; Yu, Zezhong; Guo, Guangyao; Zheng, Huijian; Huang, Yun; Liu, Liping; Lin, Jie; Long, Jinlan; Pan, Renyao; Chen, Xi; Wang, Changgui; Zhang, Wenjie; Xu, Zhenshu
免疫/内分泌
细胞生物学
发育与干细胞
多发性骨髓瘤
干细胞
骨髓瘤
发表日期：2025
文献求助 收藏